Impressively, stathmin overexpression is associated with poor survival and local or distant metastasis formation in several types of human cancer including lung cancer [11], esophageal carcinoma [12], breast cancer [17], cholangiocarcinoma [18], hepatocellular carcinoma [4, 20], gastric cancer [22, 23, 25], pancreatic cancer [27] and endometrial carcinoma [33–35, 37]. The gene discussed is STMN1; the disease is lung cancer.